Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | REGN | VRTX | BMY | ||
Company | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | ||
Open | 881.72 | 393.52 | 44.68 | ||
High | 887.48 | 399.68 | 45.37 | ||
Low | 875.22 | 393.49 | 44.34 | ||
Last | 883.20 | 397.48 | 44.85 | ||
Change | -7.48 | -0.22 | +0.15 | ||
% Change | -0.84% | -0.06% | +0.34% | ||
Volume | 505,600 | 682,400 | 21,281,900 | ||
20-Day Average Volume | 457,100 | 943,625 | 13,205,370 | ||
Previous Close | 890.68 | 397.70 | 44.70 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 918.54 | 401.28 | 49.47 | ||
20-Day Raw Stochastic | 8.40% | 21.25% | 5.16% | ||
20-Day Relative Strength | 33.09% | 42.53% | 29.15% | ||
Weighted Alpha | +9.82 | +14.78 | -34.43 | ||
Today's Opinion | 8% Sell | 8% Buy | 88% Sell | ||
Previous Opinion | 8% Buy | 8% Buy | 88% Sell | ||
Last Month's Opinion | 80% Buy | 56% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -1.52% since 04/19/24 | +0.81% since 04/19/24 | -8.34% since 04/19/24 | ||
Low | 875.22 on 04/26/24 | 393.00 on 04/25/24 | 44.34 on 04/26/24 | ||
High | 915.70 on 04/24/24 | 406.86 on 04/23/24 | 49.56 on 04/22/24 | ||
1-Month | |||||
%Chg | -8.34% since 03/26/24 | -5.01% since 03/26/24 | -14.65% since 03/26/24 | ||
Low | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 44.34 on 04/26/24 | ||
High | 976.75 on 03/27/24 | 421.45 on 04/01/24 | 54.47 on 03/28/24 | ||
3-Month | |||||
%Chg | -6.05% since 01/26/24 | -7.60% since 01/26/24 | -9.76% since 01/26/24 | ||
Low | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 44.34 on 04/26/24 | ||
High | 998.33 on 02/28/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | ||
6-Month | |||||
%Chg | +11.51% since 10/26/23 | +10.02% since 10/26/23 | -15.33% since 10/26/23 | ||
Low | 769.19 on 10/27/23 | 341.90 on 11/16/23 | 44.34 on 04/26/24 | ||
High | 998.33 on 02/28/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 96,941,800 | 102,732,288 | 90,900,144 | ||
Shares Outstanding, K | 109,762 | 258,459 | 2,026,759 | ||
Annual Sales | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 | ||
Annual Net Income | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 | ||
Last Quarter Sales | 3,434,300,000 | 2,517,700,000 | 11,477,000,000 | ||
Last Quarter Net Income | 1,159,600,000 | 968,800,000 | 1,762,000,000 | ||
60-Month Beta | 0.11 | 0.35 | 0.39 | ||
Per-Share Information | |||||
Most Recent Earnings | 11.86 on 02/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | ||
Latest Earnings Date | 05/02/24 | 05/06/24 | 04/25/24 | ||
Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | ||
Next Ex-Dividends Date | N/A | N/A | 04/04/24 | ||
Ratios | |||||
Price/Earnings ttm | 23.70 | 29.59 | 6.08 |